SCHEMBL10123519

SCHEMBL10123519

N/C1=C(\C(=O)O)CCCCCCCC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.32
▸ ALDH1A1 P00352 6/20 0.32
▸ PARP1 P09874 1/20 0.32
▸ PARP15 Q460N3 1/20 0.32
▸ PARP10 Q53GL7 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ DHODH Q02127 1/20 0.32
▸ KDM4E B2RXH2 2/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ HPGD P15428 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ GRIK1 P39086 1/20 0.31
▸ SLC6A2 P23975 1/20 0.31
▸ SLC6A4 P31645 1/20 0.31
▸ SLC6A3 Q01959 1/20 0.31
▸ TRIM24 O15164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4023693 1.00 TSHR (0.32) TSHRALDH1A1PARP1PARP15PARP10
SCHEMBL2209103 0.95 — —
SCHEMBL16087240 0.83 — —
SCHEMBL14081363 0.82 KDM4E (0.38) ALDH1A1PARP1PARP15PARP10KDM4E
SCHEMBL8197869 0.82 KDM4E (0.38) ALDH1A1PARP1PARP15PARP10KDM4E
SCHEMBL17024327 0.80 DHODH (0.41) TSHRALDH1A1PARP1PARP15PARP10
SCHEMBL17024326 0.80 DHODH (0.41) TSHRALDH1A1PARP1PARP15PARP10
SCHEMBL12491709 0.80 DHODH (0.41) TSHRALDH1A1PARP1PARP15PARP10
SCHEMBL217840 0.80 DHODH (0.41) TSHRALDH1A1PARP1PARP15PARP10
SCHEMBL12491707 0.80 DHODH (0.41) TSHRALDH1A1PARP1PARP15PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120122890-A1 Potassium Channel Modulators ABBOTT LABORATORIES (US) 2012-05-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122890-A1 Potassium Channel Modulators KCNQ1, KCNQ2, KCNQ3 TSHR 1158/4885ALDH1A1 2393/4885PARP1 3675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback